Prelude Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,134
| Closed | -$374K | – | 1475 |
|
|
2024
Q2 | $374K | Sell |
1,134
-3,470
| -75% | -$1.14M | 0.03% | 610 |
|
|
2024
Q1 | $1.82M | Buy |
4,604
+2,910
| +172% | +$1.15M | 0.1% | 231 |
|
|
2023
Q4 | $596K | Buy |
+1,694
| New | +$596K | 0.04% | 370 |
|
|
2021
Q3 | – | Sell |
-771
| Closed | -$277K | – | 1751 |
|
|
2021
Q2 | $277K | Buy |
+771
| New | +$277K | 0.01% | 991 |
|
|
2020
Q4 | – | Sell |
-152
| Closed | -$42K | – | 1615 |
|
|
2020
Q3 | $42K | Buy |
+152
| New | +$42K | ﹤0.01% | 891 |
|
|
2020
Q2 | – | Sell |
-234
| Closed | -$36K | – | 1741 |
|
|
2020
Q1 | $36K | Sell |
234
-273
| -54% | -$42K | ﹤0.01% | 542 |
|
|
2019
Q4 | $76K | Buy |
507
+485
| +2,205% | +$72.7K | ﹤0.01% | 821 |
|
|
2019
Q3 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 1102 |
|
|
2019
Q1 | – | Sell |
-56
| Closed | -$5K | – | 1794 |
|
|
2018
Q4 | $5K | Buy |
+56
| New | +$5K | ﹤0.01% | 1271 |
|
|
2014
Q3 | – | Sell |
-1,011
| Closed | -$43K | – | 2025 |
|
|
2014
Q2 | $43K | Sell |
1,011
-555
| -35% | -$23.6K | 0.01% | 1277 |
|
|
2014
Q1 | $69K | Buy |
+1,566
| New | +$69K | 0.01% | 1029 |
|
|
2013
Q4 | – | Sell |
-160
| Closed | -$7K | – | 1821 |
|
|
2013
Q3 | $7K | Buy |
+160
| New | +$7K | ﹤0.01% | 1257 |
|